The Surem TRAF3IP2 Level and Atherosclerotic Plaque Development in Human

Clinical trial NCT05945394 · UNKNOWN

Trial details

NCT number: NCT05945394
Sponsor: Nanjing Medical University
Status: UNKNOWN
Study type: OBSERVATIONAL

Coronary Heart Disease, Susceptibility to, 1

Start date: 2023-09-01
Primary completion: 2023-10-31
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.